India’s indigenous vaccine COVAXIN shows efficacy rate of 93% against severe Covid-19, 65% against Delta variant in phase 3 clinical trials
Hyderabad, July 03 India’s indigenous vaccine COVAXIN has showed an efficacy of 77.8 per cent in symptomatic Covid-19 cases in
Read more